NUP214 and cardiac hypertrophy: Li et al. found that carvedilol effectively reverses cardiac hypertrophy in AKAP5-deficient mice by normalizing the activity of cardiac CaN and calcium/calmodulin-dependent protein kinase II (CaMKII) (Li et al., 2014).